Johnson & Johnson

    JNJ ·NYSE ·Pharmaceutical Preparations ·Inc. in NJ
    Loading chart...

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-07-23 10-Q expected by 2026-08-07 (in 83 days)
    • ~2026-10-21 10-Q expected by 2026-11-05 (in 173 days)
    • ~2027-02-10 10-K expected by 2027-02-24 (in 285 days)
    • ~2027-04-21 10-Q expected by 2027-05-06 (in 355 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-22 10-Q Quarterly Report
    • 2026-04-14 8-K Earnings Release; Other Events; Financial Statements and Exhibits
    • 2026-02-11 10-K Annual Report
    • 2026-01-21 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-10-22 10-Q Quarterly Report
    • 2025-10-14 8-K Earnings Release; Other Events; Financial Statements and Exhibits
    • 2025-09-09 8-K Officer/Director Change
    • 2025-07-24 10-Q Quarterly Report
    • 2025-07-16 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-06-10 8-K Officer/Director Change
    • 2025-04-30 8-K Officer/Director Change; Shareholder Vote Results; Financial Statements and Exhibits
    • 2025-04-23 10-Q Quarterly Report
    • 2025-04-15 8-K Earnings Release; Other Events; Financial Statements and Exhibits
    • 2025-02-26 8-K Other Events; Financial Statements and Exhibits
    • 2025-02-20 8-K Other Events; Financial Statements and Exhibits